Adalimumab/etanercept/infliximab: Secondary syphilis: case report

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1396, 2012-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab/etanercept/infliximab: Weight gain: case report

Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Adalimumab/etanercept/infliximab: Psoriasis (first report with adalimumab): 5 case reports

Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Adalimumab/etanercept/infliximab: Extrapulmonary active tuberculosis: case report

Reactions Weekly, Vol. 1, Iss. 1331, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Adalimumab/etanercept/infliximab: Glomerulonephritis (first report for adalimumab and infliximab): 5 case reports

Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Adalimumab/etanercept/infliximab: Bronchospasm (first report with etanercept and infliximab): 5 case reports

Reactions Weekly, Vol. 1, Iss. 1110, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite